Shopping Cart
Remove All
Your shopping cart is currently empty
Maftivimab
(Synonyms: REGN3470-3471-3479) Copy Product Info
🥰Excellent
Synonyms: REGN3470-3471-3479
Catalog No. T77078 Copy Product Info
🥰Excellent
Maftivimab is a human monoclonal antibody targeting the glycoprotein (GP) of Zaire ebolavirus (EBOV). It is important to note that Maftivimab is one of the three core components of the Inmazeb cocktail (comprising Atoltivimab, Maftivimab, and Odesivimab, which target distinct, non-overlapping epitopes). Maftivimab neutralizes viral virulence by specifically binding to the viral surface glycoprotein, effectively blocking the process of viral entry into host cells. It has been approved for the treatment of Zaire ebolavirus infection, showing significant efficacy in reducing mortality rates and clearing viral loads.
Cas No. 2135632-36-7
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $247 | 2-4 weeks | 2-4 weeks | |
| 5 mg | $622 | 2-4 weeks | 2-4 weeks | |
| 10 mg | $996 | 2-4 weeks | 2-4 weeks |
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
With extensive experience in compound synthesis, we can provide rapid custom synthesis services for this product according to your research needs.
For research use only—not for human use. No sales to individuals. Use as intended only.
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
Antibody Information
Storage & Solubility Information
| Description | Maftivimab is a human monoclonal antibody targeting the glycoprotein (GP) of Zaire ebolavirus (EBOV). It is important to note that Maftivimab is one of the three core components of the Inmazeb cocktail (comprising Atoltivimab, Maftivimab, and Odesivimab, which target distinct, non-overlapping epitopes). Maftivimab neutralizes viral virulence by specifically binding to the viral surface glycoprotein, effectively blocking the process of viral entry into host cells. It has been approved for the treatment of Zaire ebolavirus infection, showing significant efficacy in reducing mortality rates and clearing viral loads. |
| Synonyms | REGN3470-3471-3479 |
| Reactivity | Virus |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Formulation | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Uniprot ID | |
| Target | Ebola |
| Cas No. | 2135632-36-7 |
| Isotype | IgG1 |
| Storage | Store at low temperature Store at -20°C Shipping with blue ice/Shipping at ambient temperature. |
Calculator
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: Maftivimab chemical structure
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.